Angle PLC Announces ANGLE launch of Portrait Flex assay
LAUNCH OF PORTRAIT FLEX CIRCULATING TUMOR CELL ASSAYThe Portrait Flex assay provides tailored analyses performed as a service by ANGLE's...
Cancer
Turnstone Biologics Corp. Reports Second Quarter 2023 Financial Results and Provides Business Update
Successfully closed upsized IPO, raising $88 million in gross proceeds to continue advancing pipeline of Selected TIL Therapy programsCash position...
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEW YORK and SAN DIEGO, Sept. 01, 2023 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company...
Nexcella Announces Dr. Suzanne Lentzsch, Director of the Multiple Myeloma and Amyloidosis Program at the College of Physicians and Surgeons of Columbia University and at New York Presbyterian Hospital in New York, Joins Scientific Advisory Board
Dr. Lentzsch joins the Nexcella Scientific Advisory Board with decades of experience treating patients with AL Amyloidosis and multiple myeloma...
Immix Biopharma Announces Dr. Suzanne Lentzsch, Director of the Multiple Myeloma and Amyloidosis Program at the College of Physicians and Surgeons of Columbia University and at New York Presbyterian Hospital in New York, Joins Scientific Advisory Board
Dr. Lentzsch joins the Nexcella Scientific Advisory Board with decades of experience treating patients with AL Amyloidosis and multiple myeloma...
Boditech Med and SphingoTec close Market Development Agreement to Boost Commercialization of Kidney Function Biomarker PenKid
In 2022, Boditech Med and SphingoTec closed a global licensing agreement to develop and offer the Proenkephalin A 119-159 (penKid)...
Sickle Cell Warrior Program from The National Marrow Donor Program® (NMDP)/Be The Match® Expands Access to Bone Marrow Transplant as a Curative Treatment
During Sickle Cell Awareness Month, NMPD/Be The Match reminds individuals to visit SickleCellConnect.com to access essential resources, learn more about...
The International Myeloma Foundation Welcomes Global Leader & Patient Advocate Emma Hatcher as Global VP of Patient Engagement & Advocacy
LOS ANGELES, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) announced today that global leader and patient...
Biomea Fusion Announces Appointment of Juan Pablo Frías, M.D. as Chief Medical Officer
Industry veteran and prominent diabetes clinical development expert to oversee Biomea’s progressing clinical development of novel covalent menin inhibitor BMF-219...
Femasys Inc. Obtains Medical Device Establishment License from Health Canada
ATLANTA, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs...
BriaCell Accepts Letter of Intent from Weill Cornell Medicine Outlining Plans to Initiate a Clinical Trial of Bria-IMT™ in High-Risk Early-Stage Triple Negative Breast Cancer
PHILADELPHIA and VANCOUVER, British Columbia, Aug. 31, 2023 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell”...
Peak Bio, Inc., Announces Appointment of Michael Friedman to Board of Directors
Pleasanton, CA, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Peak Bio, Inc. ("Peak Bio" or the "Company") (OTC PK: PKBO), is a...
Interim report January – June 2023
STOCKHOLM, SE / ACCESSWIRE / August 30, 2023 / Promore Pharma (STO:PROMO)(FRA:8T0)April to JuneNet sales amounted to MSEK 0.1 (0)Net...
Raymond A. Wood Foundation Reveals Caregiver Burden in Pioneering Craniopharyngioma Study
Unmet Needs and Elevated Risk of Depression: The Challenges Faced by Caregivers of Noncancerous Brain Tumor SurvivorsOCEAN CITY, MD /...
The Science Times Publishes Article About Jaguar Health’s Focus on Developing Crofelemer for Two Rare Disease Indications
Jaguar is supporting investigator-initiated proof-of-concept studies of crofelemer for the rare disease indications of short bowel syndrome and microvillus inclusion...
XBiotech Announces Enrollment Completion of Phase II, Placebo Controlled, Multicenter Study for Natrunix in Pancreatic Cancer
AUSTIN, Texas, Aug. 30, 2023 (GLOBE NEWSWIRE) -- XBiotech Inc. announced today completion of enrollment of the Phase II portion...
Annual Results – Momentum Building on our Commercial Plans
MELBOURNE, Australia, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader...
Veru to Present at the H.C. Wainwright 25th Annual Global Investment Conference on September 11th, 2023
MIAMI, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing...
Orion Corporation: Managers’ transactions – Hilpi Rautelin
ORION CORPORATION MANAGERS’ TRANSACTIONS 30 AUGUST 2023 at 15.30 EEST Orion Corporation: Managers’ transactions – Hilpi Rautelin Orion Corporation has...
Todos Announces Notice of Allowance From USPTO for Patent Application Covering Use of Compositions In Tollovid™ and Tollovir™ Ingredients
Claims covering inhibition of 3CL protease, inflammation and autophagy underscore Dr. Dorit Arad’s lifelong work NEW YORK, NY, ALPHARETTA, GA...